MELBOURNE, Australia, December 5, 2025 (EZ Newswire) -- iNGENū CRO, a global contract research organization, has set out the ...

Austin-based Natera is expanding its cancer detection capabilities with the $450 million acquisition of Colorado diagnostics ...

Discover how the Impact of R&D on Biotech Companies in India is driving innovation, boosting exports and transforming pharma, ...

The companies Cogent Biosciences, Braveheart Bio, and AAVantgarde bagged the biggest biotech funding rounds overall in ...

Creador’s purchase of shares from Peak XV comes about a decade after the venture capital firm first invested in the company.

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

Management has positioned bezuclastinib as a potential alternative to Blueprint Medicines' (BPMT) Ayvakit. This PDGFRα/c-KIT ...

French biotech company Abivax SA started the year with a market value of less than $500 million. After a meteoric rally, it’s ...

RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking ...

A decades-old way to bridge buyers and sellers on price, contingent value rights have recently seen an uptick in use due to a ...

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this ...

The partnership will focus on Crescent’s PD-1/VEGF inhibitor CR-001 and Kelun-Biotech’s SKB105, both of which the companies ...